Fox Run Management L.L.C. bought a new stake in shares of Steris PLC (NYSE:STE) during the 3rd quarter, Holdings Channel reports. The fund bought 2,329 shares of the medical equipment provider’s stock, valued at approximately $266,000.
Other large investors also recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in Steris in the second quarter worth $116,000. Fort L.P. purchased a new position in Steris in the second quarter worth $121,000. Centaurus Financial Inc. purchased a new position in Steris in the second quarter worth $184,000. ARP Americas LP purchased a new position in Steris in the second quarter worth $212,000. Finally, Empirical Finance LLC purchased a new position in Steris in the second quarter worth $216,000. 88.77% of the stock is currently owned by institutional investors.
Several research analysts have weighed in on STE shares. Zacks Investment Research cut Steris from a “hold” rating to a “sell” rating in a research report on Monday, August 6th. JMP Securities boosted their price objective on Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research report on Thursday, August 9th. Stephens reissued a “buy” rating and issued a $125.00 price objective on shares of Steris in a research report on Thursday, August 9th. Finally, KeyCorp boosted their price objective on Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 9th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $100.86.
Steris (NYSE:STE) last issued its earnings results on Wednesday, August 8th. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.01. The firm had revenue of $638.76 million for the quarter, compared to analyst estimates of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. The business’s revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.85 earnings per share. As a group, research analysts predict that Steris PLC will post 4.71 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, September 27th. Shareholders of record on Wednesday, August 29th were paid a $0.34 dividend. The ex-dividend date was Tuesday, August 28th. This is a positive change from Steris’s previous quarterly dividend of $0.31. This represents a $1.36 annualized dividend and a dividend yield of 1.28%. Steris’s payout ratio is presently 32.77%.
In other Steris news, VP Karen L. Burton sold 1,300 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $114.39, for a total value of $148,707.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.38% of the company’s stock.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Further Reading: What does the Dow Jones Industrial Average (DJIA) measure?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.